Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Shareholders' Equity (Tables)

v3.20.2
Note 10 - Shareholders' Equity (Tables)
9 Months Ended
Sep. 30, 2020
Notes Tables  
Common Stock Reserved for Future Issuance [Table Text Block]
   
September
30, 2020
 
Stock options outstanding
   
1,395,399
 
Deferred share units outstanding
   
47,237
 
Shares available for grant under the DiaMedica Therapeutics Inc. Omnibus Incentive Plan
   
1,107,431
 
Common shares issuable under common share purchase warrants
   
265,000
 
Total
   
2,815,067